Home ›› 31 Dec 2022 ›› Asia Biz

Indian maker of cough syrup linked to Uzbekistan deaths halts production

Agencies . New Delhi
31 Dec 2022 00:00:00 | Update: 31 Dec 2022 00:34:08
Indian maker of cough syrup linked to Uzbekistan deaths halts production
Inspectors reportedly found deviation from rules on manufacturing at one of the cough syrup maker Marion Biotech’s units – Courtesy Photo

The Indian maker of a cough syrup that was linked to the death of 19 children in Uzbekistan has halted production of all medicines after an inspection by the drug regulator, India’s health minister and the company said on Friday.

Health Minister Mansukh Mandaviya said investigations were continuing, and production was suspended at the Marion Biotech unit in Noida, outside Delhi, while a senior executive for the firm said they were awaiting reports following the inspection, reports Reuters.

“All manufacturing activities of Marion Biotech at Noida unit have been stopped yesterday night, while further investigation is ongoing,” Mandaviya wrote on Twitter on Friday.

Hasan Harris, Marion Biotech’s legal head, told Reuters partner ANI, “We await the reports, the factory was inspected. We’ve halted production of all medicines.” Neither Marion Biotech or the health ministry immediately responded to a Reuters request for comment on media reports that inspectors had found some deviation from rules on manufacturing at one of the firm’s production units. On Thursday, Uzbek media reported a 19th victim, with the death of a one-year-old child. Uzbekistan’s health ministry had earlier said at least 18 children died in Samarkand city after consuming Marion Biotech’s Dok-1 Max syrup.

Uzbekistan’s health ministry had said the syrup contained a toxic substance, ethylene glycol, and was administered in doses higher than the standard dose for children, either by their parents, who mistook it for an anti-cold remedy, or on the advice of pharmacists.

India’s ministry of chemicals and fertilizers issued an order on Thursday, laying out specifications to regulate the sale of ethylene glycol from the end of March.

Uzbekistan has taken legal action against a representative of the company in the Central Asian country, and has ordered all pharmacies to withdraw the Dok-1 Max tablets and syrups.

Uzbek news website uzdaily.uz on Friday reported that sales of all Marion Biotech medicines were temporarily suspended in Uzbekistan, citing the country’s Pharmaceuticals Industry Development Agency.

×